# Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection

> **NCT02401477** · PHASE4 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 90 (actual)

## Conditions studied

- Helicobacter Infections

## Interventions

- **DRUG:** Ilaprazole + Amoxicillin

## Key facts

- **NCT ID:** NCT02401477
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401477, "Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02401477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*